Lessons from Autism on Accelerating Drug Development

The genomic revolution promises to unlock the underlying mechanism of many rare diseases and disorders, but progress in translating new discoveries into therapies that benefit patients can be frustratingly slow. We spoke to Robert Ring, former chief scientific officer of Autism Speaks, about innovative efforts he’s been involved with to overcome bottlenecks in translational medicine, advance research, and attract investment into drug development.

Episode metadata supplied by the publisher feed · Published Aug 24, 2016

Embed this episode

Attribution link and audio player

NOW PLAYING

Lessons from Autism on Accelerating Drug Development

0:00 21:27

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of RARECast?

This episode is 21 minutes long.

When was this RARECast episode published?

This episode was published on August 24, 2016.

Can I download this RARECast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!